Remdesivir

Revision as of 23:04, 21 March 2020 by Ihearttroponin (talk | contribs)

Administration

  • Type: Antiviral
  • Dosage Forms: 100 mg, 200 mg
  • Routes of Administration: IV
  • Common Trade Names: N/a

Adult Dosing

  • Loading dose: 200 mg IV administered on day 1
  • Maintenance dose: 100 mg IV daily for duration of hospitalization, up to 10 days[1]

Pediatric Dosing

  • Not studied in pediatric patients

Special Populations

Pregnancy Rating

  • No data

Lactation risk

  • No data

Renal Dosing

  • Adult: Unknown
  • Pediatric: Unknown

Hepatic Dosing

  • Adult: Unknown
  • Pediatric: Unknown

Contraindications

  • Allergy to class/drug

Adverse Reactions

Serious

  • Unknown

Common

  • Unknown

Pharmacology

  • Half-life:
  • Metabolism:
  • Excretion:

Mechanism of Action

Comments

See Also

References

  1. ↑ Gilead Sciences. Study to Evaluate the Safety and Antiviral Activity of Remdesivir (GS-5734™) in Participants With Severe Coronavirus Disease (COVID-19). Available from: https://clinicaltrials.gov/ct2/show/NCT04292899. NLM identifier: NCT04292899. Accessed March 21, 2020.
Retrieved from "https://www.wikem.org/w/index.php?title=Remdesivir&oldid=249285"